Title:【2024 September Cancer Prevention And Treatment Minimally Invasive Technology Sharing Session】 Invite you to join us!    Time:From September 7th to 9th 2024    online free consultation appointment!
Title:【2024 September Cancer Prevention And Treatment Minimally Invasive Technology Sharing Session】 Invite you to join us!      Time:From September 7th to 9th 2024      online free consultation appointment!
Xiang Qide
  • Views:82
  • 2024-07-09
  • Share
DirectorChief Physician
Chief Physician
Specialty: He is specialized in combination therapy including chemotherapy, targeted therapy, immunotherapy and other treatments for lung cancer, breast cancer, colorectal cancer, liver cancer, stomach cancer, esophageal cancer, lymphoma, head and neck cancer....

Personal introduction:


Oncologist, Chief Physician. A member of Chinese Society of Clinical Oncology (CSCO) of the Chinese Anti-Cancer Association. 


Education Background: 


He graduated from the Department of Clinical Medicine of the University of South China. 


Medical experience: 


He has engaged himself in the medical oncology for more than 30 years, specializing in the clinical diagnosis and treatment of malignant tumors. Having engaged in advance studies in well-known cancer hospitals in China for many times, Prof. Xiang Qide has rich clinical experience in the integrated treatment of malignant tumors. He is specialized in combination therapy including chemotherapy, targeted therapy, immunotherapy and other treatments for lung cancer, breast cancer, colorectal cancer, liver cancer, stomach cancer, esophageal cancer, lymphoma, head and neck cancer. Especially, he excels in diagnostic bronchoscopy, bronchoscopy-guided tumor resection, tumor ablation, stent implantation and other diagnosis and treatment technology. He has published more than ten academic papers in national and provincial professional academic journals.

Form
Patient's Name *
Cancer type *
Phone number/Whatsapp *
age
email
Medical reports*
Contact us *
Appointment Form Online Consultation [email protected] BACKTOP
Leave
a message